Leadership & Team
Prof. Steffen Hering
Chief Executive Officer & FounderExpert in pharmacology of ion channels with over 45 years of research experience. While serving as a professor of pharmacology and toxicology at the University of Vienna he founded ChanPharm in 2014. CEO of ChanPharm since 2019.
Dr. Igor Baburin
Head of Patch Clamp ServicesLeads ChanPharm's patch clamp operations, overseeing manual and automated electrophysiology across a broad range of ion channel targets. Expert in assay design, pharmacological profiling, and quality control of patch clamp data.
Dr. Clara Hoebart
Head of Cardiotoxicity TeamLeads ChanPharm's cardiotoxicity team, overseeing hiPSC-derived cardiomyocyte models and cardiac safety studies. Manages cell culture workflows and ensures high-quality preparations for MEA and patch clamp-based cardiotoxicity profiling.
MSc. Sara Meschini
Head of Quality ManagementOversees quality management at ChanPharm, ensuring compliance with scientific and regulatory standards across all service workflows.
Dr. Ilayda Soztekin
Head of Patch Clamp UnitLeads ChanPharm's patch clamp unit, managing day-to-day electrophysiology operations and supporting assay development across manual and automated platforms.
Dr. Stanislav Beyl
Head of Data AnalysisLeads data analysis and scientific reporting at ChanPharm. Responsible for processing and interpreting electrophysiology datasets, developing analytical pipelines, and delivering clear, publication-ready reports to clients.